Imperial Wins International Creative Awards. Learn More

Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies
  • About
    • News
    • Corporate Responsibility
  • Contact
    • Career Opportunities
    • Contact Imperial
  • Blog
  • Marketplace
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies
  • About
    • News
    • Corporate Responsibility
  • Contact
    • Career Opportunities
    • Contact Imperial
  • Blog
  • Marketplace
Search results for

"writing"

    The clinical trials industry relies heavily on print and digital materials for patient recruitment and retention.
    Clinical Trial Writing and DesignPatient Engagement

    Writing Patient-Friendly Clinical Trial Materials: 3 Steps to Simplify Language & Increase Readability

    by William McEwen June 24, 2021
    written by William McEwen

    Introduction

    The clinical trials industry relies heavily on print and digital materials for patient recruitment and retention. To be effective, these materials must connect with the audience. There are many ways to make this connection, from writing clinical trial materials to design.

    One way to disconnect is writing at a reading level that is too high. Overlooking the importance of readability can impede participation in trials.

    It’s easy to make this mistake. Our audience likely has a reading level that is lower than our own. As life science professionals, we communicate in precise language. When we take our study from protocol to patient, a translation of sorts into a broader readability level is needed. Big words can be sublimely precise, but using them in patient materials puts you in danger of losing your reader. Reducing the reading level of our pieces when writing clinical trial materials for patients is important.

    If writing at a broader reading level doesn’t come naturally to you, read on. (And a quick note – here we are addressing materials for adult audiences, not pediatric studies.)

    Step 1

    Write clinical trial materials at the reading level you most easily write to. You will look for ways to improve readability later.

    Trying to accomplish too much can be stifling. Begin by getting the necessary information down on paper, and don’t worry about the reading level. Write each sentence the way you would normally, in a way that comes naturally to you.

    As you move from rough draft to first draft — changing, fixing, and improving — perform all your necessary wordsmithing as usual. Again, don’t concern yourself with the readability level. That will come later.

    And now that your first draft is done, it is time for the next step.

    Step 2

    Translate your text into patient-friendly language.

    Once you have written a good first draft, check the readability statistics and evaluate according to the reading level of your audience. On Microsoft Word, these statistics pop up at the end of the spelling & grammar check feature. This gives you raw data about your document, including the number of words, the average number of words per sentence, and the Flesch-Kincaid Grade Level.

    Next, examine your perfectly crafted sentences for opportunities to broaden the readability level. What reading level should you aim for? The U.S. literacy rate is seventh to eighth grade, which is 12 to 14 years old. Is that level sufficient, or should you aim lower? There are plenty of people on either side of average, and aiming more broadly can help you reach a bigger audience. We find that sixth grade often feels about right.

    A patient flyer is likely to contain less medical jargon than, say, a visit-by-visit guide or a patient diary. Some documents will require more work.

    What to assess when writing clinical study materials for patients:

    Medical terms:

    Are they known to your audience? For example, if your study is recruiting sciatica patients, your audience may know what sciatica means. So it stays, but you may want to add an explanation in plain language terms such as sciatica (pain in the back, hip, and outer side of the leg) to ensure clarity. If your study is the lung disease pneumonoultramicroscopicsilicovolcanoconiosis, there is no getting around that, either. It stays too, but a short explanation may be helpful to the reader. Also, consider if the use of abbreviations or acronyms will be understandable to your audience, and be sure to write them out the first time (e.g., hypertension [HTN]).

    Look for things that are long:
    • Long words? Reduce the syllables.
    • Long sentences? Reduce the number of words.
    • Long paragraphs? Reduce the number of sentences.
    Examples of common non-medical words that can be changed to increase readability:
    • Participate: take part
    • Reduce: lower
    • Confirm: make sure
    • Evaluate: find
    • Modify: change
    • Determine: find out
    Examples of medical terms that can be changed or explained in a few words to improve readability:
    • Treatment-resistant: Treatment doesn’t work well
    • Effectiveness/efficacy: How well the [drug or procedure] works
    • Titrate: Change the dose of a medicine

    It’s OK to retain a big word if it is necessary – just define it. Here is an example:

    Shots will be given sequentially (one after the other).

    A bullet list is a good way to rework a paragraph into distinct thoughts. Here is an example of changing some words and moving to a bullet list format. I have also added a line at the end that defines placebo:

    Original paragraph:

    Participants will be randomized (like flipping a coin) into two treatment arms. One arm will receive the study drug, and the other arm will receive a placebo.

    Revision:

    People who take part in this study will be placed by chance (like flipping a coin) into 1 of 2 groups:

    • One group will receive the study drug
    • One group will receive a placebo

    A placebo looks just like the study drug, but it contains no active medicine.

    The revision takes up more space, but the information is communicated in a clearer way.

    A note about numbers. The standard rule in writing is to spell out numbers one through nine and use Arabic numbers for 10 and above. Let’s agree that we can break that rule for ease of readability in our patient materials.

    Step 3

    Make sure you didn’t take it too far.

    Before you consider your masterpiece finished, give it a fresh look. Did you reduce the reading level too severely? It’s possible to overdo it. As you read through, ask yourself:

    Did I change or lose the meaning of a word?

    For example, changing migraine to headache is probably too vague.

    Did I go too far, perhaps alienating skilled readers and patients who are very knowledgeable about their indication?

    For example, when writing clinical trial materials for a study enrolling patients who have already experienced a few rounds of chemotherapy similar to the study drug, the reader has a knowledge base and can most likely handle text with fewer explanations.

    Did I leave out any important points?

    For example:

    Original sentence: It is possible the study drug will help patients recover from [disease being studied] more quickly.

    Revision to reflect the protocol more completely: Study doctors will see if the study drug safely helps patients recover more quickly from [disease being studied] and see how well their bodies handle it.

    Final thoughts

    1. When writing clinical trial materials, don’t let others sabotage your efforts. Your text is likely to go to others for their approval and/or edits. Let them know your text is written for patient-friendly readability and ask that they keep that in mind when making any changes.
    2. It’s up to you. Even though that reading level number can stay the same, go up, or go down as you make text changes, don’t give it too much control. It’s a guide. You be the judge of your text.
    3. Beginning with a first draft that isn’t at your audience’s reading level may seem like an unnecessary extra step. But give this method a try, and you may find that it actually streamlines the process and makes your final draft stronger.

    Have you found ways to make your writing more patient-friendly? Please share your tips in the comment box near the bottom of this page. Also, our blog about using plain language when writing patient-facing clinical trial materials provides additional information to effectively reach the patient audience.

    Updated: 28 JULY 2022

    June 24, 2021 0 comment
    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Writing and Design

    Writing for Clinical Trial Patients, Sites, and Providers

    by William McEwen November 15, 2019
    by William McEwen November 15, 2019

    At Imperial, we generate millions of words for the clinical trial industry every year. Millions? Something like that, anyway. We specialize in writing recruitment, retention, and professional materials for clinical studies and we’ve just released our latest ebook called 6 Essentials When Writing Content for…

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Writing and DesignTranslation of Study Materials

    Writing clinical trial content for translation: How to hit a home run

    by William McEwen August 14, 2019
    by William McEwen August 14, 2019

    Oh wait, the title of this blog would not translate easily. A translator once told me that baseball idioms, used frequently in the United States, are difficult to translate. While baseball is popular in the U.S., experience with the sport and associated expressions vary globally.…

    0 FacebookTwitterLinkedinEmail
  • Business InsightsClinical Trial Writing and Design

    Engaging Primary Providers: Writing Right for Your Clinical Study

    by Carol Moshier August 8, 2018
    by Carol Moshier August 8, 2018

    Communicating effectively and engaging clinical trial primary care providers by way of electronic and print materials is essential to clinical study success.  This can be difficult because physicians and other health care providers have a demanding schedule with little time between patient visits, rounds, and…

    0 FacebookTwitterLinkedinEmail
  • Business InsightsClinical Trial Writing and Design

    4 Tips for Writing for Patients in Clinical Trials

    by Erica Manning June 13, 2018
    by Erica Manning June 13, 2018

    Writing for patients can be tricky. Now, layer in the unique challenges of those participating in clinical research trials. Intimidated? Don’t be. By sticking to a few parameters, you can write content for clinical trial participants that is purposeful, engaging, and doesn’t cause a compliance…

    0 FacebookTwitterLinkedinEmail
  • Business InsightsClinical Trial Writing and Design

    Writing Clinical Trial Content by Committee: Getting Everyone on the Same Page

    by Erica Manning May 31, 2018
    by Erica Manning May 31, 2018

    The more the merrier? Sure, there are many times when that holds true, but not when it comes to having multiple players contribute to writing clinical trial content. Do you sometimes feel like your documents are constantly stuck in the review process? You are likely…

    0 FacebookTwitterLinkedinEmail
  • Patient Recruitment and RetentionSite Materials & Logistics

    Clinical Study Startup and Execution: Hidden Causes Behind Big Delays

    by Dan McDonald October 21, 2022
    by Dan McDonald October 21, 2022

    Before you plan your next study, please read this first. Planning and conducting a clinical trial presents numerous challenges, and we find that many sponsors and CROs repeatedly miss important areas when planning their studies. These planning gaps result in: Delayed clinical study startup Missing…

    2 FacebookTwitterLinkedinEmail
  • Ancillary Trial Supplies and EquipmentClinical Trial Writing and DesignPatient EngagementPatient Recruitment and RetentionSite Materials & LogisticsTranslation of Study Materials

    Clinical Trial Efficiencies: The Power of a Single Workstream

    by Dan McDonald August 18, 2022
    by Dan McDonald August 18, 2022

    The management time needed to corral many different elements during a trial is immense. In the buildup to a research study, clinical operations teams often focus on items such as study startup, site initiation and activation, supply chain, monitoring, data management, and safety. And there…

    1 FacebookTwitterLinkedinEmail
  • Translation of Study Materials

    Machine Translation: OK for Your Clinical Trial Materials?

    by Sian Jones February 15, 2022
    by Sian Jones February 15, 2022

    The number of global trials grows every year, with study teams reaching out to increasingly diverse patient populations. These broader populations bring a growing variety of languages, cultures, and experiences – all of which need to be considered when recruiting or interacting with clinical trial…

    0 FacebookTwitterLinkedinEmail
  • Life-Science Events

    DPHARM Conference Hits Year 11: Driven by COVID, it Delivers its Proof of Concept

    by Dan McDonald October 5, 2021
    by Dan McDonald October 5, 2021

    Like many conferences in the COVID era, DPHARM, the annual conference based in Boston and focused on disruptive innovations in clinical trials, moved from in-person to a virtual setting this week, due to local spikes of the Delta variant. To date, I’ve largely avoided these…

    1 FacebookTwitterLinkedinEmail
  • 1
  • 2
  • 3

Welcome

Welcome

The Imperial blog features content of interest to life-science professionals, with a special focus on clinical trials. We hope you will enjoy our experts’ perspectives, and invite you to join the conversation by leaving your comments. Please let us know of any additional topics you would like to see covered here.

Keep in touch

Twitter Linkedin Youtube Email RSS

Popular Posts

  • 1

    Google Translate: The Unwitting Confidentiality Flaw

    April 15, 2020
  • 2

    25 Reasons People Aren’t Enrolling in Your Clinical Trial

    October 29, 2015
  • 3

    See Do Get

    August 12, 2014
  • 4

    Clinical Trial Supply Chains: The Key to Avoiding Disruptions

    May 10, 2022
  • 5

    COVID-19 Brings Pressure Testing to Ancillary Supplies and Equipment

    May 4, 2021

Categories

  • Ancillary Trial Supplies and Equipment (13)
  • Business Insights (101)
  • Clinical Trial Writing and Design (20)
  • Life-Science Events (43)
  • Patient Engagement (13)
  • Patient Recruitment and Retention (74)
  • Site Materials & Logistics (28)
  • Study Site Management (17)
  • Translation of Study Materials (15)
  • Uncategorized (1)
Imperial Clinical Research Services Blog

Imperial CRS is a global leader in clinical trial solutions and support, specializing in study and site print materials, ancillary trial supplies and equipment, clinical trial translation management, and clinical trial patient engagement.

Imperial CRS Corporate Headquarters
3100 Walkent Drive NW
Grand Rapids, MI 49544

Contact

connect@imperialcrs.com

800.777.2591

020 3887 3437

Employment

Social

© Imperial CRS, Inc. | Privacy Policy